Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2022 08:00 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics to Report Third Quarter 2022 Financial Results on November 3, 2022

SAN RAFAEL, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
September 06, 2022 16:05 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference

SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
July 28, 2022 16:05 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics Reports Second Quarter 2022 Results

RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
July 21, 2022 08:00 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
June 13, 2022 08:00 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients

First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis RICHMOND, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...
May 26, 2022 07:00 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer

RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
May 17, 2022 16:05 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference

RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...
April 28, 2022 16:05 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics Reports First Quarter 2022 Results

RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
April 21, 2022 08:03 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics to Report First Quarter 2022 Financial Results on April 28

RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
February 24, 2022 16:05 ET | Source: Ekso Bionics Holdings, Inc.

Ekso Bionics Reports Fourth Quarter and Year End 2021 Results

RICHMOND, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right